Comparaison des effets de l’aprotinine et de l’acide tranexamique sur le saignement en chirurgie cardiaque

[1]  C. Guenther.  Pro: tranexamic acid is better than aprotinin in decreasing bleeding after cardiac surgery. , 1994, Journal of cardiothoracic and vascular anesthesia.

[2]  J. Murkin.  Con: tranexamic acid is not better than aprotinin in decreasing bleeding after cardiac surgery. , 1994, Journal of cardiothoracic and vascular anesthesia.

[3]  F. Camu,et al.  Intraoperative coronary thrombosis: can aprotinin and protamine be incriminated? , 1994, Journal of cardiothoracic and vascular anesthesia.

[4]  D. Royston.  Intraoperative coronary thrombosis: can aprotinin be incriminated? , 1994, Journal of cardiothoracic and vascular anesthesia.

[5]  W. van Oeveren,et al.  Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass. , 1993, The Journal of thoracic and cardiovascular surgery.

[6]  J. Haberer,et al.  Anaphylactic reaction to aprotinin during cardiac surgery , 1993, Anaesthesia.

[7]  R. Weisel,et al.  Prevention of postbypass bleeding with tranexamic acid and ϵ-aminocaproic acid , 1993 .

[8]  S. Bélisle,et al.  Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients , 1993, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[9]  O. Jegaden,et al.  Aprotinin does not compromise arterial graft patency in coronary bypass operations. , 1993, The Journal of thoracic and cardiovascular surgery.

[10]  Z. Su,et al.  Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery , 1993 .

[11]  R. Colman,et al.  Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion. , 1993, The Journal of thoracic and cardiovascular surgery.

[12]  G. Hempelmann,et al.  Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss. , 1993, The Journal of thoracic and cardiovascular surgery.

[13]  S. Westaby.  Aprotinin in perspective. , 1993, The Annals of thoracic surgery.

[14]  T. Treasure,et al.  Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom. , 1993, The Annals of thoracic surgery.

[15]  M. Jochum,et al.  Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations , 1993 .

[16]  J. Fareed,et al.  Effects of aprotinin on anticoagulant monitoring: implications in cardiovascular surgery. , 1993, The Annals of thoracic surgery.

[17]  G. Hempelmann,et al.  Platelet function in cardiac surgery: influence of temperature and aprotinin. , 1993, The Annals of thoracic surgery.

[18]  R. Karp,et al.  Monitoring of heparin-induced anticoagulation with kaolin-activated clotting time in cardiac surgical patients treated with aprotinin. , 1992, Anesthesiology.

[19]  E. Berreklouw,et al.  Low-dose aprotinin in internal mammary artery bypass operations contributes to important blood saving. , 1992, The Annals of thoracic surgery.

[20]  F. Loop,et al.  Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. , 1992, The Annals of thoracic surgery.

[21]  R. Weintraub,et al.  Comparison of two transfusion strategies after elective operations for myocardial revascularization. , 1992, The Journal of thoracic and cardiovascular surgery.

[22]  S. Khuri,et al.  Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. , 1992, The Journal of thoracic and cardiovascular surgery.

[23]  J. Desroches,et al.  Natural and synthetic antifibrinolytics in cardiac surgery , 1992, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[24]  D. Royston.  High-dose aprotinin therapy: a review of the first five years' experience. , 1992, Journal of cardiothoracic and vascular anesthesia.

[25]  J. Soria,et al.  Hemostasis in Patients Undergoing Extracorporeal Circulation: The Effect of Aprotinin (Trasylol) , 1991, Thrombosis and Haemostasis.

[26]  D. V. Van Riper,et al.  Hemostatic Effects of Tranexamic Acid and Desmopressin During Cardiac Surgery , 1991, Circulation.

[27]  J. Horrow,et al.  Effect of tranexamic acid on platelet ADP during extracorporeal circulation , 1991, American journal of hematology.

[28]  J. Mathew,et al.  Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. , 1991, Anesthesiology.

[29]  V. Tilsner,et al.  The effects of aprotinin on hemostatic function during cardiac surgery. , 1991, Journal of cardiothoracic and vascular anesthesia.

[30]  R. Hillman,et al.  Platelet activation and aggregation during cardiopulmonary bypass. , 1991, Anesthesiology.

[31]  H. Teufelsbauer,et al.  Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation. , 1991, The Journal of thoracic and cardiovascular surgery.

[32]  J. E. Doran,et al.  Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. , 1991, The Journal of thoracic and cardiovascular surgery.

[33]  F. Sebening,et al.  Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. , 1990, Anesthesiology.

[34]  D. Cosgrove,et al.  Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). , 1989, The Journal of thoracic and cardiovascular surgery.

[35]  M. Abdelnoor,et al.  Tranexamic acid (Cyklokapron) is not necessary to reduce blood loss after coronary artery bypass operations. , 1993, The Journal of thoracic and cardiovascular surgery.

[36]  R. Mohr,et al.  Platelet protection by low-dose aprotinin in cardiopulmonary bypass: electron microscopic study. , 1993, The Annals of thoracic surgery.

[37]  X. Moreau,et al.  Choc anaphylactique lors de l'utilisation de l'aprotinine à fortes doses en chirurgie cardiaque , 1993 .

[38]  J. Jourdan,et al.  Aprotinine, acide tranexamique et CEC chez des patients sous aspirine , 1993 .

[39]  I. Goel,et al.  Prophylactic tranexamic acid decreases bleeding after cardiac operations. , 1990, The Journal of thoracic and cardiovascular surgery.